Trials / Completed
CompletedNCT02006342
Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis
Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine if co-administration of subcutaneous (SQ)Insulin glargine in combination with intravenous (IV) insulin decreases the time to resolution of ketoacidosis and requirement for ICU admission compared to IV insulin with delayed administration of SQ glargine for the treatment of diabetic ketoacidosis (DKA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin Glargine | |
| DRUG | Regular Insulin |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-12-10
- Last updated
- 2017-05-16
- Results posted
- 2017-05-16
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02006342. Inclusion in this directory is not an endorsement.